Therapeutic uses of chemokine variants

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/62 (2006.01) A61K 38/19 (2006.01) A61P 29/00 (2006.01) A61P 31/00 (2006.01) A61P 37/00 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2536082

Variants of homodimer-forming chemokines, such as human CCL2, having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds and acting as an obligate monomer, can antagonize natural chemokines and have anti-inflammatory activity in vivo. These variants can be used as active ingredient in pharmaceutical compositions for the treatment of inflammatory, autoimmune, or infectious diseases.

L'invention concerne des variants de chemokines formant des homodimères, tels que CCL2 humain, qui comprennent une seule substitution acide aminé dans l'interface de dimérisation modifiant le motif de liaisons hydrogène et agissant comme un monomère obligatoire, peuvent avoir des chemokines naturelles pour antagonistes et une activité anti-inflammatoire in vivo. Ces variants peuvent être utilisés comme ingrédient actif dans des compositions pharmaceutiques pour traiter des maladies inflammatoires, auto-immunes ou infectieuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic uses of chemokine variants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic uses of chemokine variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of chemokine variants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1855212

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.